Hugo joined MVM in 2005. Before joining MVM, he qualified as a chartered accountant with KPMG. Hugo has a degree in Molecular and Cellular Biochemistry from Oxford University.
Hugo is a member of the boards of AccuVein, Inc., Vertos Medical, Inc. and eZono AG.
He was previously a director of Horizon Discovery Limited (LSE: HZD) and Vantia Limited and led MVM's investment into BioVex Limited (acquired by Amgen).
MVM Partners LLP
30 St George Street